David L. Lacey - 23 Jan 2025 Form 4 Insider Report for Arcus Biosciences, Inc. (RCUS)

Role
Director
Signature
/s/ Carolyn Tang, Attorney-in-Fact
Issuer symbol
RCUS
Transactions as of
23 Jan 2025
Net transactions value
$0
Form type
4
Filing time
27 Jan 2025, 16:30:02 UTC
Previous filing
07 Jun 2024
Next filing
19 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding RCUS Common Stock 57,652 23 Jan 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCUS Stock Option (right to buy) Award $0 +5,000 $0.000000 5,000 23 Jan 2025 Common Stock 5,000 $13.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is exercisable in 24 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company.